Abstract:Backgrounds The impaired function of endogenous bone marrow mesenchymal stem cells (BMSCs) is a determinant in the development of osteoporosis (OP). BMSCs have been described the potential relevance of autophagy to the pathogenesis of OP. However, the underlying mechanism remains unclear. Our previous researches have found leucine‐rich repeat‐containing 17 (LRRc17) secreted by MSCs, a member of the LRR superfamily, was markedly enriched in the age‐related pathways. This study aims to investigate the effects of LRRc17 in aging process of MSCs. Methods Hydrogen peroxide (H 2 O 2 ) induced aging MSCs and natural senescent cell cultivated from old and young C57BL/6 mice were used to evaluate the effects of LRRc17 on MSCs. Western blot, flow cytometry was used to detect autophagy, apoptosis and cell cycle respectively. Furthermore, mitochondrial function was measured by Mitosox, JC‐1, ATP. The mitochondrial morphology was detected by Mitotracker. Moreover, co‐culture was performed to detect the effects of LRRc17 secreted by MSCs on osteoblast (OB) and osteoclast (OC). Results MSCs exhibited a senescent phenotype after treatment with hydrogen peroxide. This result was improved after the addition of rapamycin. Interestingly, compared with the H 2 O 2 ‐treated group, MSCs transfected with shLRRc17 showed increased DNA synthesis phase, and decreased apoptosis ratio, ROS (Fig. 1A, B, C ). Autophagy related protein LC3 II, Beclin1 were up‐upregulated and P62 was down‐regulated (Fig. 1G ). And mitochondrial morphology was also significantly improved (Fig. 1D, E ). More importantly, LRRc17 reversed the loss of Ψm (Fig. 2A ) and enhanced ATP content (Fig. 1F ). Co‐culture showed that silenced LRRc17 in MSCs enhanced the osteogenic ability of OB and decreased the bone resorption capacity of OC, and the opposite result was obtained after overexpression (Fig. 2B ). Conclusions LRRc17 enhances characterizations of BMSCs through attenuating MSC senescence during OP, and which could lead to novel therapies to target altered bone formation. Support or Funding Information This work was supported by the Chengdu Giant Panda Breeding Research Foundation (2016cdspt001). Figure 1 Figure 2

Sirt3-mediated mitophagy regulates AGEs-induced BMSCs senescence and senile osteoporosis

S-sulfhydration of SIRT3 Combats BMSC Senescence and Ameliorates Osteoporosis Via Stabilizing Heterochromatic and Mitochondrial Homeostasis.

Sirt3 Attenuates Oxidative Stress Damage and Rescues Cellular Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Superoxide Dismutase 2

GW24-e2135 SIRT1 Significantly Influences Old Sourced MSCs Aging and Proliferation

Autophagy controls mesenchymal stem cell properties and senescence during bone aging

SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.

Autophagy inhibits the mesenchymal stem cell aging induced by D-galactose through ROS/JNK/p38 signalling

Targeting NAMPT‐OPA1 for treatment of senile osteoporosis

The Role of SIRT3-mediated Mitochondrial Homeostasis in Osteoarthritis

SIRT1 Ameliorates Age-Related Senescence of Mesenchymal Stem Cells Via Modulating Telomere Shelterin

Sirtuin3 protects aged human mesenchymal stem cells against oxidative stress and enhances efficacy of cell therapy for ischaemic heart diseases

Genistein mitigates senescence of bone marrow mesenchymal stem cells via ERRα-mediated mitochondrial biogenesis and mitophagy in ovariectomized rats

MiR-21-5p regulates the dynamic of mitochondria network and rejuvenates the senile phenotype of bone marrow stromal cells (BMSCs) isolated from osteoporotic SAM/P6 mice

Mitochondrial Metabolic Failure in Telomere Attrition-Provoked Aging of Bone Marrow Mesenchymal Stem Cells

Targeting Mitophagy As a Potential Therapeutic Approach for Age‐Related Bone Diseases

Sirt3 mediates the benefits of exercise on bone in aged mice

Down-regulation of LRRc17 secreted by BMSCs alleviates age-related bone aging through autophagy enchancement

Bmi-1 Epigenetically Orchestrates Osteogenic and Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells to Delay Bone Aging

Mir-203-3p Promotes Senescence of Mouse Bone Marrow Mesenchymal Stem Cells Via Downregulation of Pbk

MiR-601-induced BMSCs senescence accelerates steroid-induced osteonecrosis of the femoral head progression by targeting SIRT1

Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice